Afuco™ Anti-Human SELPLG ADCC Therapeutic Antibody (AbGn-168), ADCC Enhanced
Anti-SELPLG ADCC Enhanced Antibody (AbGn-168) is an ADCC enhanced antibody produced by our Afuco™ platform. AbGn-168H is a humanized monoclonal antibody being developed to treat inflammatory diseases, has been demonstrated in a randomized, multicenter, double-blind, placebo-controlled phase II trial in patients with moderate-to-severe plaque psoriasis. Due to the unique mechanism of action, AbGn-168H has potential benefit for treating multiple immune-related diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-533CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | SELPLG |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles. |